Recent studies have shown that ZEB1 and ZEB2 are direct targets of the miR-200 family in human breast cancer cells (MDA-MB-231), canine kidney cells (MDCK), murine models, and a NCI-60 panel of cell lines [15-17]. Here, ZEB2 is linked to breast cancer.